Informazioni sul prodotto
- (5'beta)-5'-[(2S)-butan-2-yl]-12'-hydroxy-3',6',18-trioxo-2'-(propan-2-yl)ergotaman
- (5′α)-12′-Hydroxy-2′-(1-methylethyl)-5′-[(1S)-1-methylpropyl]ergotaman-3′,6′,18-trione
- 5'alpha(S)-sec-Butyl-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione
- 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3′,6′,18-trione deriv.
- Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-(1-methylethyl)-5′-(1-methylpropyl)-, [5′α(S)]-
- Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-(1-methylethyl)-5′-[(1S)-1-methylpropyl]-, (5′α)-
- Indolo[4,3-fg]quinoline, ergotaman-3′,6′,18-trione deriv.
- beta-Ergocryptine
- beta-Ergokryptine
- β-Ergocryptine
- Vedi altri sinonimi
- β-Ergokryptine
Ergocryptine is a drug that is used to treat Parkinson’s disease. It is an active metabolite of the ergot alkaloid ergometrine. It has been shown in studies using polyclonal antibodies and casein to inhibit spontaneous activity in rats, as well as citric acid production from perennial ryegrass. Ergocryptine also inhibits biosynthesis of ergocryptine and chemical ionization of peptones from purpurea strain. It is structurally similar to ergometrine, but it does not have the same physiological effects because it lacks the methyl group on the nitrogen atom at position 2.
Proprietà chimiche
Richiesta tecnica su: 3D-FE40777 b-Ergocryptine
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
